MiR-10b-3p alleviates cerebral ischemia/reperfusion injury by targeting Krüppel-like factor 5 (KLF5)
- PMID: 34989875
- DOI: 10.1007/s00424-021-02645-9
MiR-10b-3p alleviates cerebral ischemia/reperfusion injury by targeting Krüppel-like factor 5 (KLF5)
Abstract
Although miR-10b-3p has been identified to be involved in cerebral ischemia injury, its impact and specific mechanism in cerebral ischemia injury remain unclear. The effects of Mir-10b-3p were investigated by establishing rat and cell models of ischemia/reperfusion (I/R) injury. Oxygen-glucose deprivation/reperfusion (OGD/R) was performed on pheochromocytoma-12 (PC12) cells. MiR-10b-3p expression levels in brain tissues and PC12 cells were detected by qRT-PCR. The impacts of miR-10b-3p on neurological deficits, infarct volume, inflammatory factor expression, in vivo brain water content, cell viability, and cell apoptosis were assessed. The relationship between miR-10b-3p and KLF5 was determined by TargetScan and luciferase reporter assay. The rescue experiments were performed to confirm the role of this axis in cerebral ischemia injury. Mir-10b-3p levels in rat brain tissue and PC12 cells were significantly decreased after I/R injury. MiR-10b-3p overexpression obviously reduced neurological deficits, infarct volume, brain water content, inflammatory factors expression, and neuronal apoptosis in the brain of ischemia-stroked rats. Meanwhile, miR-10b-3p upregulation also inhibited cell viability and apoptosis of OGD/R-induced PC12 cells. Besides, KLF5 was identified as a target of miR-10b-3p, and rescue experiments revealed that KLF5 was involved in the regulation of miR-10b-3p in ischemic injury. Our results demonstrated that miR-10b-3p had the neuroprotective effects against ischemia injury by targeting KLF5 and provided a potential underlying target for ischemic stroke treatment.
Keywords: Apoptosis; Ischemia/reperfusion (I/R); KLF5; miR-10b-3p.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Inhibition of miR-19a-3p decreases cerebral ischemia/reperfusion injury by targeting IGFBP3 in vivo and in vitro.Biol Res. 2020 Apr 20;53(1):17. doi: 10.1186/s40659-020-00280-9. Biol Res. 2020. PMID: 32312329 Free PMC article.
-
MiR-10b-3p Protects Cerebral I/R Injury through Targeting Programmed Cell Death 5 (PDCD5).Crit Rev Eukaryot Gene Expr. 2021;31(6):85-98. doi: 10.1615/CritRevEukaryotGeneExpr.2021039465. Crit Rev Eukaryot Gene Expr. 2021. PMID: 34936294
-
LncRNA MALAT1 improves cerebral ischemia-reperfusion injury and cognitive dysfunction by regulating miR-142-3p/SIRT1 axis.Int J Neurosci. 2023 Jul;133(7):740-753. doi: 10.1080/00207454.2021.1972999. Epub 2023 Feb 2. Int J Neurosci. 2023. PMID: 34461809
-
MicroRNA-193b-3p alleviates focal cerebral ischemia and reperfusion-induced injury in rats by inhibiting 5-lipoxygenase expression.Exp Neurol. 2020 May;327:113223. doi: 10.1016/j.expneurol.2020.113223. Epub 2020 Feb 4. Exp Neurol. 2020. PMID: 32032565
-
Preclinical Evidence of Paeoniflorin Effectiveness for the Management of Cerebral Ischemia/Reperfusion Injury: A Systematic Review and Meta-Analysis.Front Pharmacol. 2022 Apr 8;13:827770. doi: 10.3389/fphar.2022.827770. eCollection 2022. Front Pharmacol. 2022. PMID: 35462929 Free PMC article.
Cited by
-
Silencing lncRNA GABPB1-AS1 alleviates cerebral ischemia reperfusion injury through the miR-641/NUCKS1 axis.Am J Transl Res. 2024 Jul 15;16(7):2963-2972. doi: 10.62347/EAGK7098. eCollection 2024. Am J Transl Res. 2024. PMID: 39114718 Free PMC article.
-
LncRNA 148400 Promotes the Apoptosis of Renal Tubular Epithelial Cells in Ischemic AKI by Targeting the miR-10b-3p/GRK4 Axis.Cells. 2022 Dec 9;11(24):3986. doi: 10.3390/cells11243986. Cells. 2022. PMID: 36552750 Free PMC article.
-
Defining the molecular response to ischemia-reperfusion injury and remote ischemic preconditioning in human kidney transplantation.PLoS One. 2024 Oct 29;19(10):e0311613. doi: 10.1371/journal.pone.0311613. eCollection 2024. PLoS One. 2024. PMID: 39471208 Free PMC article.
-
A Bibliometric and Visualization Analysis of Metabolic Reprogramming in Cardiovascular Diseases: Trends, Key Contributors, and Future Directions from 2000 to 2024.Curr Cardiol Rev. 2025;21(4):e1573403X371021. doi: 10.2174/011573403X371021250109064231. Curr Cardiol Rev. 2025. PMID: 40513070 Free PMC article. Review.
-
The Role of microRNAs in Epigenetic Regulation of Signaling Pathways in Neurological Pathologies.Int J Mol Sci. 2023 Aug 17;24(16):12899. doi: 10.3390/ijms241612899. Int J Mol Sci. 2023. PMID: 37629078 Free PMC article. Review.
References
-
- Bansal A, Prathap R, Gupta S, Chaurasia A, Chaudhary P (2019) Role of microRNAs in stroke recovery. J Family Med Primary Care 8:1850–1854. https://doi.org/10.4103/jfmpc.jfmpc_296_19 - DOI
-
- Bulygin KV, Beeraka NM, Saitgareeva AR, Nikolenko VN, Gareev I (2020) Can miRNAs be considered as diagnostic and therapeutic molecules in ischemic stroke pathogenesis?-Current status. Int J Mol Sci 21(18):6728. https://doi.org/10.3390/ijms21186728 - DOI - PMC
-
- Clark WM, Lessov NS, Dixon MP, Eckenstein F (1997) Monofilament intraluminal middle cerebral artery occlusion in the mouse. Neurol Res 19:641–648. https://doi.org/10.1080/01616412.1997.11740874 - DOI - PubMed
-
- Duan X, Gan J, Peng DY, Bao Q, Xiao L, Wei L, Wu J (2019) Identification and functional analysis of microRNAs in rats following focal cerebral ischemia injury. Mol Med Rep 19:4175–4184. https://doi.org/10.3892/mmr.2019.10073 - DOI - PubMed - PMC
-
- Eyileten C, Wicik Z (2018) MicroRNAs as diagnostic and prognostic biomarkers in ischemic stroke-a comprehensive review and bioinformatic analysis. Cells 7(12):249. https://doi.org/10.3390/cells7120249 - DOI - PMC
MeSH terms
Substances
LinkOut - more resources
Full Text Sources